levodopa has been researched along with baclofen in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (42.42) | 18.7374 |
| 1990's | 4 (12.12) | 18.2507 |
| 2000's | 5 (15.15) | 29.6817 |
| 2010's | 7 (21.21) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bissada, NK; Finkbeiner, AE; Welch, LT | 1 |
| Halbhübner, K; Herken, H; Loos, D | 1 |
| Jacob, JJ; Ramabadran, K | 1 |
| Lees, AJ; Shaw, KM; Stern, GM | 1 |
| Gerlach, J | 1 |
| Calne, DB | 1 |
| Coper, H; Hausmanowa-Petrusewicz, I; Kaminska, A; Ossowska, K; Schulze, G; Wolfarth, S | 1 |
| Chokroverty, S; Hening, WA; Walters, AS | 1 |
| Persson, B; Rubenson, A; Sillén, U | 1 |
| Andrade, LA; Bertolucci, PH; Pereira, JS | 1 |
| Coletti, A; Mandelli, A; Minoli, G; Tredici, G | 1 |
| Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
| Goetz, CG; Klawans, HL; Tanner, CM | 1 |
| Ortiz, A | 1 |
| Dahlström, S; Koulu, M; Lammintausta, R | 1 |
| Bédard, PJ; Gomez-Mancilla, B | 1 |
| Matsuoka, H; Mizoguchi, K; Nishimura, Y; Obi, T; Takatsu, M | 1 |
| Goldstein, M | 1 |
| Fernández-Alvarez, E | 1 |
| Camargos, S; Cardoso, F; Lees, AJ; Singleton, A | 1 |
| Kaminska, M; Lin, JP; Lumsden, DE; Tomlin, S | 1 |
| Abu-Arafeh, I; Combe, L | 1 |
| Blumberger, DM; Chen, R; Daskalakis, ZJ; Pollock, BG; Rajji, TK; Salavati, B; Zomorrodi, R | 1 |
| Balint, B; Bhatia, KP; Jankovic, J; Mencacci, NE; Pisani, A; Rothwell, J; Valente, EM; Vidailhet, M | 1 |
| Choi, JH; Jeon, B; Kim, HJ; Kim, R; Park, S; Shin, J; Woo, KA; Yoo, D | 1 |
| Bohn, E; Falck-Ytter, Y; Fehlings, D; Goren, K; Switzer, L | 1 |
| Adiao, KJ; Prado, MB | 1 |
10 review(s) available for levodopa and baclofen
| Article | Year |
|---|---|
Uropharmacology: X. Central nervous system stimulants and depressants.
Topics: Amphetamines; Anesthetics; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Baclofen; Benzodiazepines; Central Nervous System Agents; Chloral Hydrate; Humans; Imipramine; Levodopa; Meperidine; Meprobamate; Morphine; Nortriptyline; Paraldehyde; Phenothiazines; Phenytoin; Picrotoxin; Reserpine; Strychnine; Urinary Tract | 1979 |
Drug treatment of spasticity and rigidity.
Topics: Amantadine; Baclofen; Diazepam; Humans; Levodopa; Mephenesin; Muscle Rigidity; Parasympatholytics; Phenols; Phenothiazines; Spasm; Spinal Nerve Roots | 1975 |
Review and videotape recognition of idiopathic restless legs syndrome.
Topics: Anti-Anxiety Agents; Arousal; Baclofen; Benzodiazepines; Bromocriptine; Carbamazepine; Clonidine; Humans; Levodopa; Narcotics; Restless Legs Syndrome; Sleep Stages; Videotape Recording | 1991 |
[Tardive dyskinesia: I. Physiopathology and treatment].
Topics: Animals; Antipsychotic Agents; Baclofen; Binding Sites; Dopamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Neurons; Receptors, Dopamine; Receptors, GABA-A; Reserpine | 1984 |
The treatment of cerebral palsy: What we know, what we don't know.
Topics: Activities of Daily Living; Baclofen; Botulinum Toxins, Type A; Brain; Cerebral Palsy; Complementary Therapies; Dopamine; Evidence-Based Medicine; Humans; Levodopa; Muscle Relaxants, Central; Muscle Spasticity; Neuromuscular Agents; Neuronal Plasticity; Physical Therapy Modalities; Rhizotomy; Stem Cell Transplantation; Treatment Outcome | 2004 |
Movement disorders in children: recent advances in management.
Topics: Age Distribution; Age of Onset; Baclofen; Benzodiazepines; Child; Child, Preschool; Cholinergic Antagonists; Dopamine Agents; Drug Therapy, Combination; Dyskinesias; Early Diagnosis; Electromyography; Female; Humans; Incidence; Infant; Levodopa; Male; Movement Disorders; Physical Examination; Prognosis; Risk Assessment; Severity of Illness Index; Sex Distribution; Spain; Treatment Outcome | 2009 |
Dystonia.
Topics: Baclofen; Basal Ganglia; Botulinum Toxins, Type A; Dopamine Agents; Dystonia; Dystonic Disorders; GABA-B Receptor Agonists; GTP Cyclohydrolase; Humans; Levodopa; Neuromuscular Agents; Quality of Life | 2018 |
Patient-reported responses to medical treatment in primary dystonia.
Topics: Baclofen; Benzodiazepines; Dystonic Disorders; Female; Humans; Levodopa; Male; Medical Records; Patient Reported Outcome Measures; Treatment Outcome; Trihexyphenidyl | 2020 |
Pharmacological and neurosurgical interventions for individuals with cerebral palsy and dystonia: a systematic review update and meta-analysis.
Topics: Baclofen; Botulinum Toxins; Cerebral Palsy; Clonidine; Deep Brain Stimulation; Dystonia; Humans; Injections, Spinal; Levodopa; Neurosurgical Procedures; Trihexyphenidyl | 2021 |
Corticobasal syndrome etiologies in a young Filipino patient: A case report and literature review.
Topics: Adult; Baclofen; Corticobasal Degeneration; Donepezil; Dopamine Agents; Fatal Outcome; GABA-B Receptor Agonists; Humans; Levodopa; Male; Nootropic Agents; Philippines | 2021 |
2 trial(s) available for levodopa and baclofen
| Article | Year |
|---|---|
Baclofen in Parkinson's disease.
Topics: Aged; Aminobutyrates; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Parkinson Disease | 1978 |
Pharmacological Manipulation of Cortical Inhibition in the Dorsolateral Prefrontal Cortex.
Topics: Adult; Baclofen; Cholinesterase Inhibitors; Cross-Over Studies; Dextromethorphan; Dopamine Agents; Double-Blind Method; Electroencephalography; Excitatory Amino Acid Antagonists; Female; GABA-B Receptor Agonists; Humans; Levodopa; Male; Neural Inhibition; Prefrontal Cortex; Rivastigmine; Transcranial Magnetic Stimulation; Young Adult | 2018 |
21 other study(ies) available for levodopa and baclofen
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Experimental neuropathy with Parkinson-like muscular rigidity. A suitable model for testing dopaminergic agonists and neuroleptic drugs.
Topics: 6-Aminonicotinamide; Animals; Antipsychotic Agents; Baclofen; Brain; Brain Chemistry; Bromocriptine; Central Nervous System Diseases; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Electromyography; Gluconates; Levodopa; Lisuride; Male; Motor Neurons; Muscle Contraction; Niacinamide; Parkinson Disease, Secondary; Rats; Reserpine; RNA; Spinal Cord; Sugar Phosphates | 1978 |
Facilitatory effect of naloxone and involvement of specific ligand-opiate receptor system in the antinociceptive effects of non-opioid drugs.
Topics: Analgesics; Animals; Baclofen; Benperidol; Haloperidol; Levodopa; Male; Mice; Naloxone; Phosphodiesterase Inhibitors; Pimozide; Receptors, Opioid; Sympathomimetics | 1978 |
The relationship between parkinsonism and tardive dyskinesia.
Topics: Age Factors; Aminobutyrates; Baclofen; Basal Ganglia; Biperiden; Choline; Dopamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Methyltyrosines; Mouth; Parkinson Disease; Piperidines; Tranquilizing Agents | 1977 |
General discussion of drug therapy in dystonia.
Topics: Adolescent; Age Factors; Baclofen; Cannabis; Carbamazepine; Child; Child, Preschool; Dystonia Musculorum Deformans; Female; Haloperidol; Humans; Levodopa; Male; Phytotherapy; Torticollis | 1976 |
Muscle stiffness and continuous electromyographic activity in old rats; an animal model for spasticity?
Topics: Aging; Animals; Atrophy; Baclofen; Benserazide; Drug Combinations; Electromyography; Female; Levodopa; Muscle Contraction; Muscle Denervation; Muscle Spasticity; Muscle Tonus; Muscles; Rats; Rats, Wistar | 1992 |
Central effects of baclofen on the L-dopa induced hyperactive urinary bladder of the rat.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Baclofen; Bicuculline; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Injections, Intraventricular; Levodopa; Male; Naloxone; Rats; Rats, Inbred Strains; Substance P; Urinary Bladder | 1985 |
Post-anoxic action myoclonus (Lance-Adams syndrome) treated with levodopa and GABAergic drugs.
Topics: Anticonvulsants; Baclofen; Drug Therapy, Combination; Female; gamma-Aminobutyric Acid; Humans; Hypoxia; Levodopa; Middle Aged; Myoclonus | 1980 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
The pharmacology of olivopontocerebellar atrophy.
Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans; Levodopa; Male; Middle Aged; Olivary Nucleus; Pons; Propranolol; Syndrome | 1984 |
Neuropharmacological profile of Meige's disease: overview and a case report.
Topics: Aged; Baclofen; Benztropine; Clonazepam; Doxepin; Drug Therapy, Combination; Dystonia; Facial Muscles; Haloperidol; Humans; Levodopa; Male; Spasm | 1983 |
Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion.
Topics: Adult; Apomorphine; Baclofen; Diazepam; Dopamine; gamma-Aminobutyric Acid; Growth Hormone; Humans; Levodopa; Male; Valproic Acid | 1980 |
Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Atropine; Baclofen; Clonidine; Dopamine Agents; Drug Interactions; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Meperidine; Methoxydimethyltryptamines; Neurotransmitter Agents; Yohimbine | 1993 |
Muscle cramp as the result of impaired GABA function--an electrophysiological and pharmacological observation.
Topics: Amyotrophic Lateral Sclerosis; Baclofen; Clomipramine; Diazepam; Electric Stimulation; Evoked Potentials; GABA Antagonists; gamma-Aminobutyric Acid; Humans; Levodopa; Lidocaine; Male; Middle Aged; Motor Neurons; Muscle Cramp; Muscular Atrophy, Spinal; Nerve Block; Neural Conduction; Sensory Thresholds; Ulnar Nerve | 1993 |
DYT16: the original cases.
Topics: Adolescent; Adult; Age of Onset; Anti-Dyskinesia Agents; Antiparkinson Agents; Baclofen; Biperiden; Botulinum Toxins; Carbidopa; Child; Child, Preschool; Cholinergic Antagonists; Drug Combinations; Drug Resistance; Dystonia; Dystonic Disorders; Female; Humans; Levodopa; Male; Middle Aged; Muscle Relaxants, Central; Mutation; Parkinsonian Disorders; Pedigree; Phenotype; RNA-Binding Proteins; Speech Disorders; Trihexyphenidyl; Young Adult | 2012 |
Medication use in childhood dystonia.
Topics: Adolescent; Antiparkinson Agents; Baclofen; Child; Chloral Hydrate; Cohort Studies; Diazepam; Drug-Related Side Effects and Adverse Reactions; Dystonia; Dystonic Disorders; Female; Humans; Hypnotics and Sedatives; Levodopa; Logistic Models; Male; Muscle Relaxants, Central; Risk Factors; Trihexyphenidyl | 2016 |
Status dystonicus in children: Early recognition and treatment prevent serious complications.
Topics: Adolescent; Anti-Dyskinesia Agents; Athetosis; Baclofen; Cerebral Palsy; Child; Disease Progression; Dystonia; Female; Fluid Therapy; Humans; Infections; Levodopa; Male; Muscle Relaxants, Central; Retrospective Studies; Treatment Outcome | 2016 |